Cell‑in‑a‑Box® for Pancreatic Cancer
Pancreatic adenocarcinoma
Phase 1/2Active
Key Facts
About Austrianova Biotechnology
Austrianova delivers a patented cell‑encapsulation platform for immune‑protected, off‑the‑shelf cell and probiotic therapies.
View full company profileTherapeutic Areas
Other Pancreatic adenocarcinoma Drugs
| Drug | Company | Phase |
|---|---|---|
| DOC1021 | Diakonos Oncology | Phase 1 |
| Alpha DaRT | Alpha Tau Medical | Feasibility/Pilot |